Ferumoxytol magnetic resonance angiography: a dose-finding study in patients with chronic kidney disease.

Sokratis StoumposMartin HennessyAlex T VeseyAleksandra RadjenovicRam KasthuriDavid B KingsmorePatrick B MarkGiles Roditi

Published in: European radiology (2019)

• Ferumoxytol is used off-label as an MRI contrast agent but dose-related data are lacking. • In patients with CKD requiring MR angiography, a dose of 3 mg/kg provides excellent vascular enhancement.

Keyphrases

magnetic resonance
contrast enhanced
optical coherence tomography
computed tomography
magnetic resonance imaging
big data
electronic health record